Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$648439.0.

  • Volitionrx's Other Working Capital Changes fell 3443.25% to -$648439.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$595077.0, marking a year-over-year decrease of 10457.16%. This contributed to the annual value of -$257204.0 for FY2024, which is 10197.85% down from last year.
  • Per Volitionrx's latest filing, its Other Working Capital Changes stood at -$648439.0 for Q3 2025, which was down 3443.25% from $224407.0 recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Other Working Capital Changes peaked at $13.2 million during Q4 2023, and registered a low of -$890197.0 during Q4 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$25235.0 (2023), whereas its average is $1.3 million.
  • Per our database at Business Quant, Volitionrx's Other Working Capital Changes surged by 272814.02% in 2021 and then tumbled by 338221.71% in 2023.
  • Over the past 5 years, Volitionrx's Other Working Capital Changes (Quarter) stood at -$890197.0 in 2021, then soared by 98.59% to -$12512.0 in 2022, then soared by 105531.47% to $13.2 million in 2023, then plummeted by 100.62% to -$82446.0 in 2024, then tumbled by 686.5% to -$648439.0 in 2025.
  • Its Other Working Capital Changes was -$648439.0 in Q3 2025, compared to $224407.0 in Q2 2025 and -$88599.0 in Q1 2025.